HI Fundamental Analysis - HEALTH ITALIA SPA

Fundamental Rating

Taking everything into account, HI scores 5 out of 10 in our fundamental rating. HI was compared to 25 industry peers in the Health Care Providers & Services industry. HI scores excellent points on both the profitability and health parts. This is a solid base for a good stock. HI does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year HI was profitable.

In the past year HI had a positive cash flow from operations.

HI had positive earnings in each of the past 5 years.

In the past 5 years HI always reported a positive cash flow from operatings.

1.2 Ratios

HI has a Return On Assets of 4.16%. This is in the better half of the industry: HI outperforms 80.00% of its industry peers.

The Return On Equity of HI (6.91%) is comparable to the rest of the industry.

HI has a Return On Invested Capital (5.21%) which is in line with its industry peers.

Measured over the past 3 years, the Average Return On Invested Capital for HI is in line with the industry average of 5.78%.

		Industry Rank	Sector Rank
ROA	4.16%
ROE	6.91%
ROIC	5.21%

ROA(3y)3.96%

ROA(5y)3.25%

ROE(3y)7.81%

ROE(5y)6.83%

ROIC(3y)7.13%

ROIC(5y)6%

1.3 Margins

Looking at the Profit Margin, with a value of 7.52%, HI belongs to the top of the industry, outperforming 92.00% of the companies in the same industry.

In the last couple of years the Profit Margin of HI has grown nicely.

HI has a better Operating Margin (12.85%) than 96.00% of its industry peers.

HI's Operating Margin has improved in the last couple of years.

HI has a Gross Margin of 33.27%. This is comparable to the rest of the industry: HI outperforms 48.00% of its industry peers.

HI's Gross Margin has been stable in the last couple of years.

		Industry Rank	Sector Rank
OM	12.85%
PM (TTM)	7.52%
GM	33.27%

OM growth 3Y8%

OM growth 5YN/A

PM growth 3Y33.22%

PM growth 5Y9.47%

GM growth 3Y-1.7%

GM growth 5Y-0.8%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so HI is destroying value.

The number of shares outstanding for HI has been increased compared to 1 year ago.

HI has less shares outstanding than it did 5 years ago.

Compared to 1 year ago, HI has an improved debt to assets ratio.

2.2 Solvency

HI has an Altman-Z score of 3.04. This indicates that HI is financially healthy and has little risk of bankruptcy at the moment.

Looking at the Altman-Z score, with a value of 3.04, HI belongs to the top of the industry, outperforming 88.00% of the companies in the same industry.

The Debt to FCF ratio of HI is 15.21, which is on the high side as it means it would take HI, 15.21 years of fcf income to pay off all of its debts.

Looking at the Debt to FCF ratio, with a value of 15.21, HI is doing worse than 72.00% of the companies in the same industry.

A Debt/Equity ratio of 0.22 indicates that HI is not too dependend on debt financing.

HI has a Debt to Equity ratio of 0.22. This is amongst the best in the industry. HI outperforms 92.00% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.22
Debt/FCF	15.21
Altman-Z	3.04

ROIC/WACC0.7

WACC7.45%

2.3 Liquidity

A Current Ratio of 3.18 indicates that HI has no problem at all paying its short term obligations.

HI has a better Current ratio (3.18) than 96.00% of its industry peers.

A Quick Ratio of 3.18 indicates that HI has no problem at all paying its short term obligations.

HI's Quick ratio of 3.18 is amongst the best of the industry. HI outperforms 96.00% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	3.18
Quick Ratio	3.18

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

HI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 61.15%, which is quite impressive.

The Earnings Per Share has been growing by 181.50% on average over the past years. This is a very strong growth

Looking at the last year, HI shows a decrease in Revenue. The Revenue has decreased by -0.86% in the last year.

Measured over the past years, HI shows a small growth in Revenue. The Revenue has been growing by 2.37% on average per year.

EPS 1Y (TTM)61.15%

EPS 3Y27.76%

EPS 5Y181.5%

EPS Q2Q%504.86%

Revenue 1Y (TTM)-0.86%

Revenue growth 3Y-3.68%

Revenue growth 5Y2.37%

Sales Q2Q%-10.1%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 20.33, HI is valued on the expensive side.

The rest of the industry has a similar Price/Earnings ratio as HI.

The average S&P500 Price/Earnings ratio is at 27.54. HI is valued slightly cheaper when compared to this.

		Industry Rank	Sector Rank
PE	20.33
Fwd PE	N/A

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of HI is on the same level as its industry peers.

Based on the Price/Free Cash Flow ratio, HI is valued expensively inside the industry as 84.00% of the companies are valued cheaper.

		Industry Rank	Sector Rank
P/FCF	90.02
EV/EBITDA	10

4.3 Compensation for Growth

The decent profitability rating of HI may justify a higher PE ratio.

PEG (NY)N/A

PEG (5Y)0.11

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

HI does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

HEALTH ITALIA SPA

BIT:HI (7/10/2025, 7:00:00 PM)

285

-1 (-0.35%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Providers & Services

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst OwnersN/A

Inst Owner ChangeN/A

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap54.15M

Analysts84.44

Price Target372.3 (30.63%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DP0%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)-15.12%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	20.33
Fwd PE	N/A
P/S	1.53
P/FCF	90.02
P/OCF	17.69
P/B	1.41
P/tB	1.55
EV/EBITDA	10

EPS(TTM)14.02

EY4.92%

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)3.17

FCFY1.11%

OCF(TTM)16.11

OCFY5.65%

SpS186.12

BVpS202.44

TBVpS184.42

PEG (NY)N/A

PEG (5Y)0.11

Profitability

		Industry Rank	Sector Rank
ROA	4.16%
ROE	6.91%
ROCE	9.35%
ROIC	5.21%
ROICexc	5.54%
ROICexgc	5.97%
OM	12.85%
PM (TTM)	7.52%
GM	33.27%
FCFM	1.7%

ROA(3y)3.96%

ROA(5y)3.25%

ROE(3y)7.81%

ROE(5y)6.83%

ROIC(3y)7.13%

ROIC(5y)6%

ROICexc(3y)7.88%

ROICexc(5y)6.76%

ROICexgc(3y)8.74%

ROICexgc(5y)7.6%

ROCE(3y)12.74%

ROCE(5y)10.6%

ROICexcg growth 3Y-3.65%

ROICexcg growth 5YN/A

ROICexc growth 3Y-1.37%

ROICexc growth 5YN/A

OM growth 3Y8%

OM growth 5YN/A

PM growth 3Y33.22%

PM growth 5Y9.47%

GM growth 3Y-1.7%

GM growth 5Y-0.8%

F-Score7

Asset Turnover0.55

Health

		Industry Rank	Sector Rank
Debt/Equity	0.22
Debt/FCF	15.21
Debt/EBITDA	1.49
Cap/Depr	221.98%
Cap/Sales	6.96%
Interest Coverage	250
Cash Conversion	54.18%
Profit Quality	22.63%
Current Ratio	3.18
Quick Ratio	3.18
Altman-Z	3.04

F-Score7

WACC7.45%

ROIC/WACC0.7

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)61.15%

EPS 3Y27.76%

EPS 5Y181.5%

EPS Q2Q%504.86%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-0.86%

Revenue growth 3Y-3.68%

Revenue growth 5Y2.37%

Sales Q2Q%-10.1%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-17.66%

EBIT growth 3Y4.03%

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-71.81%

FCF growth 3YN/A

FCF growth 5Y-21.09%

OCF growth 1Y43.49%

OCF growth 3Y55.79%

OCF growth 5Y-20.58%

HEALTH ITALIA SPA (HI.MI) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens